This 2-day event brings together top-ranking researchers, clinicians, industry, and policymakers. This symposium aims to strengthen collaboration and address hurdles for implementing molecular tests in precision medicine.
The speakers will cover topics on how molecular tests can enable sustainable and cost-effective precision in the clinic, how to exploit the complex interplay between tumor and microenvironment, and tools to discover and validate clinically relevant biomarkers.
For more information about the event and to register, please visit the NorProst website – link HERE
Kristin Austlid Taskén, PhD, Project Group Leader, Professor, Institute for Cancer Research, Oslo University Hospital
Alicia Llorente, PhD, Project Leader, Senior Scientist, Oslo University Hospital
Heidi Lyng, Professor, Scientist, Doctor of Philosophy, Oslo University Hospital
Rolf Skotheim, Group Leader, Doctor of Philosophy, Professor, Biomedical Informatics Group, Oslo University Hospital
Ingrid Jenny Guldvik, M.Sc., PhD Student, Oslo University Hospital
Symposium: With supported from Oslo Cancer Cluster:
Charlotte Homme, Head of Membership & Events
Dave Tippett, Membership & Events Coordinator
Sponsored by: With support from: